Suppr超能文献

HIV-1蛋白酶一对快速和慢速结合配体的缔合途径机制

Mechanism of the Association Pathways for a Pair of Fast and Slow Binding Ligands of HIV-1 Protease.

作者信息

Huang Yu-Ming M, Raymundo Mark Anthony V, Chen Wei, Chang Chia-En A

机构信息

Department of Chemistry, University of California, Riverside , Riverside, California 92521, United States.

ChemConsulting LLC , Frederick, Maryland 21704, United States.

出版信息

Biochemistry. 2017 Mar 7;56(9):1311-1323. doi: 10.1021/acs.biochem.6b01112. Epub 2017 Feb 21.

Abstract

Equilibrium constants, together with kinetic rate constants of binding, are key factors in the efficacy and safety of drug compounds, informing drug design. However, the association pathways of protein-ligand binding, which contribute to their kinetic behaviors, are little understood. In this work, we used unbiased all-atom molecular dynamics (MD) simulations with an explicit solvent model to study the association processes of protein-ligand binding. Using the HIV protease (HIVp)-xk263 and HIVp-ritonavir protein-ligand systems as cases, we observed that ligand association is a multistep process involving diffusion, localization, and conformational rearrangements of the protein, ligand, and water molecules. Moreover, these two ligands preferred different routes of binding, which reflect two well-known binding mechanisms: induced-fit and conformation selection models. Our study shows that xk263 has a stronger capacity for desolvating surrounding water molecules, thereby inducing a semiopen conformation of the HIVp flaps (induced-fit model). In contrast, the slow dehydration characteristic of ritonavir allows for gradual association with the binding pocket of HIVp when the protein's flap conformation is fully open (conformation selection model). By studying the mechanism of ligand association and understanding the role of solvent molecules during the binding event, we can obtain a different perspective on the mechanism of macromolecule recognition, providing insights into drug discovery.

摘要

平衡常数与结合动力学速率常数一起,是药物化合物有效性和安全性的关键因素,为药物设计提供依据。然而,蛋白质 - 配体结合的缔合途径对其动力学行为有影响,但人们对此了解甚少。在这项工作中,我们使用具有显式溶剂模型的无偏全原子分子动力学(MD)模拟来研究蛋白质 - 配体结合的缔合过程。以HIV蛋白酶(HIVp)-xk263和HIVp - 利托那韦蛋白质 - 配体系统为例,我们观察到配体缔合是一个多步骤过程,涉及蛋白质、配体和水分子的扩散、定位以及构象重排。此外,这两种配体偏好不同的结合途径,这反映了两种著名的结合机制:诱导契合和构象选择模型。我们的研究表明,xk263具有更强的使周围水分子去溶剂化的能力,从而诱导HIVp瓣片形成半开放构象(诱导契合模型)。相比之下,利托那韦的缓慢脱水特性使其在蛋白质瓣片构象完全开放时能够逐渐与HIVp的结合口袋缔合(构象选择模型)。通过研究配体缔合机制并了解结合过程中溶剂分子的作用,我们可以从不同角度看待大分子识别机制,为药物发现提供见解。

相似文献

9
Binding to the open conformation of HIV-1 protease.结合 HIV-1 蛋白酶的开放构象。
Proteins. 2011 Jul;79(7):2282-90. doi: 10.1002/prot.23054. Epub 2011 May 20.
10
Ligand Binding Pathways and Conformational Transitions of the HIV Protease.HIV蛋白酶的配体结合途径与构象转变
Biochemistry. 2018 Mar 6;57(9):1533-1541. doi: 10.1021/acs.biochem.7b01248. Epub 2018 Feb 15.

引用本文的文献

10
Prediction of Drug-Target Binding Kinetics by Comparative Binding Energy Analysis.通过比较结合能分析预测药物-靶点结合动力学
ACS Med Chem Lett. 2018 Oct 4;9(11):1134-1139. doi: 10.1021/acsmedchemlett.8b00397. eCollection 2018 Nov 8.

本文引用的文献

6
9
Pharmacokinetics and the drug-target residence time concept.药代动力学和药物靶点停留时间概念。
Drug Discov Today. 2013 Aug;18(15-16):697-707. doi: 10.1016/j.drudis.2013.02.010. Epub 2013 Mar 14.
10
Molecular recognition and ligand association.分子识别与配体结合。
Annu Rev Phys Chem. 2013;64:151-75. doi: 10.1146/annurev-physchem-040412-110047. Epub 2013 Mar 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验